Angiodynamics (ANGO) Non-Current Debt (2011 - 2023)

Angiodynamics has reported Non-Current Debt for 13 years, with the latest figure at $49.8 million in Q2 2023.

• For the quarter ending Q2 2023, Non-Current Debt rose 99.27% year-over-year to $49.8 million; the trailing twelve-month figure through May 2023 stood at $49.8 million (up 99.27% YoY), and the FY2023 full-year result was $49.8 million, up 99.27% from the prior year.
• Non-Current Debt for Q2 2023 stood at $49.8 million, roughly flat from $49.8 million in the prior quarter.
• The five-year high for Non-Current Debt was $126.8 million in Q1 2019, with the low at $14.3 million in Q1 2020.
• Historically, Non-Current Debt has averaged $45.9 million across 5 years, with a median of $40.0 million in 2020.
• Annual changes were most pronounced in 2020 — Non-Current Debt tumbled 88.69% — and 2021, when it soared 109.19%.
• Angiodynamics' Non-Current Debt stood at $124.4 million in 2019, then tumbled by 67.85% to $40.0 million in 2020, then plunged by 37.5% to $25.0 million in 2021, then soared by 99.18% to $49.8 million in 2022, then climbed by 0.04% to $49.8 million in 2023.
• The last three Non-Current Debt figures came in at $49.8 million (Q2 2023), $49.8 million (Q1 2023), and $49.8 million (Q4 2022), per Business Quant data.